Defining and measuring negative symptoms of schizophrenia in clinical trials

@article{Marder2014DefiningAM,
  title={Defining and measuring negative symptoms of schizophrenia in clinical trials},
  author={S. Marder and Brian Kirkpatrick},
  journal={European Neuropsychopharmacology},
  year={2014},
  volume={24},
  pages={737-743}
}
  • S. Marder, Brian Kirkpatrick
  • Published 2014
  • Medicine, Psychology
  • European Neuropsychopharmacology
  • Recent attention has focused on negative symptoms as a target for new therapeutic approaches including pharmacological agents, medical devices, and psychosocial treatments. Each of these approaches requires an instrument for measuring the severity of negative symptoms as well as changes in severity over time. The instrument selected should provide coverage for the domains of negative symptoms; it should be sensitive to change; it should be reliable and relatively brief; and it should be useful… CONTINUE READING

    Tables and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The main object of this study is to evaluate the efficacy of equine assisted therapy on substantial and so far unsatisfactorily treatable symptom complexes in patients with… Expand
    ConditionsAnimal Assisted Therapy
    InterventionBehavioral
    Treating Negative Symptoms in Schizophrenia: an Update
    78
    Clinical management of negative symptoms of schizophrenia: An update.
    46
    Psychometric evaluation of the negative syndrome of schizophrenia
    42

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 32 REFERENCES
    The positive and negative syndrome scale (PANSS) for schizophrenia.
    14891
    The NIMH-MATRICS consensus statement on negative symptoms.
    830
    Negative symptoms in schizophrenia. Definition and reliability.
    1481
    The structure of negative symptoms within schizophrenia: implications for assessment.
    481